Global Targeted Antitumor Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
LPI (LP Information)' newest research report, the “Targeted Antitumor Drugs Industry Forecast” looks at past sales and reviews total world Targeted Antitumor Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Antitumor Drugs sales for 2023 through 2029. With Targeted Antitumor Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Antitumor Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeted Antitumor Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Antitumor Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Targeted Antitumor Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Antitumor Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Antitumor Drugs.
The global Targeted Antitumor Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Antitumor Drugs players cover Roche, Celgene, Novartis, Johnson & Johnson, Lilly, AstraZeneca plc. and Betta Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Antitumor Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Targeted Antitumor Drugs market?
What factors are driving Targeted Antitumor Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Antitumor Drugs market opportunities vary by end market size?
How does Targeted Antitumor Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
LPI (LP Information)' newest research report, the “Targeted Antitumor Drugs Industry Forecast” looks at past sales and reviews total world Targeted Antitumor Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Antitumor Drugs sales for 2023 through 2029. With Targeted Antitumor Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Antitumor Drugs industry.
This Insight Report provides a comprehensive analysis of the global Targeted Antitumor Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Antitumor Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Targeted Antitumor Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Antitumor Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Antitumor Drugs.
The global Targeted Antitumor Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Antitumor Drugs players cover Roche, Celgene, Novartis, Johnson & Johnson, Lilly, AstraZeneca plc. and Betta Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Antitumor Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Macromolecular Targeted Antitumor Drugs
- Small Molecule Targeted Antitumor Drugs
- Lung Cancer
- Lymphoma
- Breast Cancer
- Leukaemia
- Prostate Cancer
- Multiple Bone Marrow Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Celgene
- Novartis
- Johnson & Johnson
- Lilly
- AstraZeneca plc.
- Betta Pharmaceuticals
What is the 10-year outlook for the global Targeted Antitumor Drugs market?
What factors are driving Targeted Antitumor Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted Antitumor Drugs market opportunities vary by end market size?
How does Targeted Antitumor Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Antitumor Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Targeted Antitumor Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Targeted Antitumor Drugs by Country/Region, 2018, 2022 & 2029
2.2 Targeted Antitumor Drugs Segment by Type
2.2.1 Macromolecular Targeted Antitumor Drugs
2.2.2 Small Molecule Targeted Antitumor Drugs
2.3 Targeted Antitumor Drugs Sales by Type
2.3.1 Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Targeted Antitumor Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Targeted Antitumor Drugs Sale Price by Type (2018-2023)
2.4 Targeted Antitumor Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Lymphoma
2.4.3 Breast Cancer
2.4.4 Leukaemia
2.4.5 Prostate Cancer
2.4.6 Multiple Bone Marrow Cancer
2.4.7 Others
2.5 Targeted Antitumor Drugs Sales by Application
2.5.1 Global Targeted Antitumor Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Targeted Antitumor Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Targeted Antitumor Drugs Sale Price by Application (2018-2023)
3 GLOBAL TARGETED ANTITUMOR DRUGS BY COMPANY
3.1 Global Targeted Antitumor Drugs Breakdown Data by Company
3.1.1 Global Targeted Antitumor Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Targeted Antitumor Drugs Sales Market Share by Company (2018-2023)
3.2 Global Targeted Antitumor Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Targeted Antitumor Drugs Revenue by Company (2018-2023)
3.2.2 Global Targeted Antitumor Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Targeted Antitumor Drugs Sale Price by Company
3.4 Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Antitumor Drugs Product Location Distribution
3.4.2 Players Targeted Antitumor Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TARGETED ANTITUMOR DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Antitumor Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Targeted Antitumor Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Targeted Antitumor Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Targeted Antitumor Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Targeted Antitumor Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Targeted Antitumor Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Targeted Antitumor Drugs Sales Growth
4.4 APAC Targeted Antitumor Drugs Sales Growth
4.5 Europe Targeted Antitumor Drugs Sales Growth
4.6 Middle East & Africa Targeted Antitumor Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeted Antitumor Drugs Sales by Country
5.1.1 Americas Targeted Antitumor Drugs Sales by Country (2018-2023)
5.1.2 Americas Targeted Antitumor Drugs Revenue by Country (2018-2023)
5.2 Americas Targeted Antitumor Drugs Sales by Type
5.3 Americas Targeted Antitumor Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Antitumor Drugs Sales by Region
6.1.1 APAC Targeted Antitumor Drugs Sales by Region (2018-2023)
6.1.2 APAC Targeted Antitumor Drugs Revenue by Region (2018-2023)
6.2 APAC Targeted Antitumor Drugs Sales by Type
6.3 APAC Targeted Antitumor Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Antitumor Drugs by Country
7.1.1 Europe Targeted Antitumor Drugs Sales by Country (2018-2023)
7.1.2 Europe Targeted Antitumor Drugs Revenue by Country (2018-2023)
7.2 Europe Targeted Antitumor Drugs Sales by Type
7.3 Europe Targeted Antitumor Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Antitumor Drugs by Country
8.1.1 Middle East & Africa Targeted Antitumor Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Targeted Antitumor Drugs Sales by Type
8.3 Middle East & Africa Targeted Antitumor Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs
10.3 Manufacturing Process Analysis of Targeted Antitumor Drugs
10.4 Industry Chain Structure of Targeted Antitumor Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Antitumor Drugs Distributors
11.3 Targeted Antitumor Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETED ANTITUMOR DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeted Antitumor Drugs Market Size Forecast by Region
12.1.1 Global Targeted Antitumor Drugs Forecast by Region (2024-2029)
12.1.2 Global Targeted Antitumor Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted Antitumor Drugs Forecast by Type
12.7 Global Targeted Antitumor Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Antitumor Drugs Product Portfolios and Specifications
13.1.3 Roche Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Targeted Antitumor Drugs Product Portfolios and Specifications
13.2.3 Celgene Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Targeted Antitumor Drugs Product Portfolios and Specifications
13.3.3 Novartis Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Targeted Antitumor Drugs Product Portfolios and Specifications
13.4.3 Johnson & Johnson Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Lilly
13.5.1 Lilly Company Information
13.5.2 Lilly Targeted Antitumor Drugs Product Portfolios and Specifications
13.5.3 Lilly Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lilly Main Business Overview
13.5.5 Lilly Latest Developments
13.6 AstraZeneca plc.
13.6.1 AstraZeneca plc. Company Information
13.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Portfolios and Specifications
13.6.3 AstraZeneca plc. Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca plc. Main Business Overview
13.6.5 AstraZeneca plc. Latest Developments
13.7 Betta Pharmaceuticals
13.7.1 Betta Pharmaceuticals Company Information
13.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Portfolios and Specifications
13.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Betta Pharmaceuticals Main Business Overview
13.7.5 Betta Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Antitumor Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Targeted Antitumor Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Targeted Antitumor Drugs by Country/Region, 2018, 2022 & 2029
2.2 Targeted Antitumor Drugs Segment by Type
2.2.1 Macromolecular Targeted Antitumor Drugs
2.2.2 Small Molecule Targeted Antitumor Drugs
2.3 Targeted Antitumor Drugs Sales by Type
2.3.1 Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Targeted Antitumor Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Targeted Antitumor Drugs Sale Price by Type (2018-2023)
2.4 Targeted Antitumor Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Lymphoma
2.4.3 Breast Cancer
2.4.4 Leukaemia
2.4.5 Prostate Cancer
2.4.6 Multiple Bone Marrow Cancer
2.4.7 Others
2.5 Targeted Antitumor Drugs Sales by Application
2.5.1 Global Targeted Antitumor Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Targeted Antitumor Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Targeted Antitumor Drugs Sale Price by Application (2018-2023)
3 GLOBAL TARGETED ANTITUMOR DRUGS BY COMPANY
3.1 Global Targeted Antitumor Drugs Breakdown Data by Company
3.1.1 Global Targeted Antitumor Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Targeted Antitumor Drugs Sales Market Share by Company (2018-2023)
3.2 Global Targeted Antitumor Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Targeted Antitumor Drugs Revenue by Company (2018-2023)
3.2.2 Global Targeted Antitumor Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Targeted Antitumor Drugs Sale Price by Company
3.4 Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Antitumor Drugs Product Location Distribution
3.4.2 Players Targeted Antitumor Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TARGETED ANTITUMOR DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Targeted Antitumor Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Targeted Antitumor Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Targeted Antitumor Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Targeted Antitumor Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Targeted Antitumor Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Targeted Antitumor Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Targeted Antitumor Drugs Sales Growth
4.4 APAC Targeted Antitumor Drugs Sales Growth
4.5 Europe Targeted Antitumor Drugs Sales Growth
4.6 Middle East & Africa Targeted Antitumor Drugs Sales Growth
5 AMERICAS
5.1 Americas Targeted Antitumor Drugs Sales by Country
5.1.1 Americas Targeted Antitumor Drugs Sales by Country (2018-2023)
5.1.2 Americas Targeted Antitumor Drugs Revenue by Country (2018-2023)
5.2 Americas Targeted Antitumor Drugs Sales by Type
5.3 Americas Targeted Antitumor Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Antitumor Drugs Sales by Region
6.1.1 APAC Targeted Antitumor Drugs Sales by Region (2018-2023)
6.1.2 APAC Targeted Antitumor Drugs Revenue by Region (2018-2023)
6.2 APAC Targeted Antitumor Drugs Sales by Type
6.3 APAC Targeted Antitumor Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Antitumor Drugs by Country
7.1.1 Europe Targeted Antitumor Drugs Sales by Country (2018-2023)
7.1.2 Europe Targeted Antitumor Drugs Revenue by Country (2018-2023)
7.2 Europe Targeted Antitumor Drugs Sales by Type
7.3 Europe Targeted Antitumor Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Antitumor Drugs by Country
8.1.1 Middle East & Africa Targeted Antitumor Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Targeted Antitumor Drugs Sales by Type
8.3 Middle East & Africa Targeted Antitumor Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs
10.3 Manufacturing Process Analysis of Targeted Antitumor Drugs
10.4 Industry Chain Structure of Targeted Antitumor Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Antitumor Drugs Distributors
11.3 Targeted Antitumor Drugs Customer
12 WORLD FORECAST REVIEW FOR TARGETED ANTITUMOR DRUGS BY GEOGRAPHIC REGION
12.1 Global Targeted Antitumor Drugs Market Size Forecast by Region
12.1.1 Global Targeted Antitumor Drugs Forecast by Region (2024-2029)
12.1.2 Global Targeted Antitumor Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted Antitumor Drugs Forecast by Type
12.7 Global Targeted Antitumor Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Antitumor Drugs Product Portfolios and Specifications
13.1.3 Roche Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Targeted Antitumor Drugs Product Portfolios and Specifications
13.2.3 Celgene Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Targeted Antitumor Drugs Product Portfolios and Specifications
13.3.3 Novartis Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Targeted Antitumor Drugs Product Portfolios and Specifications
13.4.3 Johnson & Johnson Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Lilly
13.5.1 Lilly Company Information
13.5.2 Lilly Targeted Antitumor Drugs Product Portfolios and Specifications
13.5.3 Lilly Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lilly Main Business Overview
13.5.5 Lilly Latest Developments
13.6 AstraZeneca plc.
13.6.1 AstraZeneca plc. Company Information
13.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Portfolios and Specifications
13.6.3 AstraZeneca plc. Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca plc. Main Business Overview
13.6.5 AstraZeneca plc. Latest Developments
13.7 Betta Pharmaceuticals
13.7.1 Betta Pharmaceuticals Company Information
13.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Portfolios and Specifications
13.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Betta Pharmaceuticals Main Business Overview
13.7.5 Betta Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Antitumor Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Targeted Antitumor Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Macromolecular Targeted Antitumor Drugs
Table 4. Major Players of Small Molecule Targeted Antitumor Drugs
Table 5. Global Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Targeted Antitumor Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Targeted Antitumor Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Targeted Antitumor Drugs Revenue by Application (2018-2023)
Table 13. Global Targeted Antitumor Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Targeted Antitumor Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Targeted Antitumor Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global Targeted Antitumor Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Targeted Antitumor Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Targeted Antitumor Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Targeted Antitumor Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution and Sales Area
Table 21. Players Targeted Antitumor Drugs Products Offered
Table 22. Targeted Antitumor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Targeted Antitumor Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Targeted Antitumor Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Targeted Antitumor Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Targeted Antitumor Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Targeted Antitumor Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Targeted Antitumor Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Targeted Antitumor Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC Targeted Antitumor Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC Targeted Antitumor Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Targeted Antitumor Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Targeted Antitumor Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Targeted Antitumor Drugs
Table 58. Key Market Challenges & Risks of Targeted Antitumor Drugs
Table 59. Key Industry Trends of Targeted Antitumor Drugs
Table 60. Targeted Antitumor Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Targeted Antitumor Drugs Distributors List
Table 63. Targeted Antitumor Drugs Customer List
Table 64. Global Targeted Antitumor Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Targeted Antitumor Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Targeted Antitumor Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Targeted Antitumor Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Targeted Antitumor Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Targeted Antitumor Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Targeted Antitumor Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Targeted Antitumor Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Roche Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Targeted Antitumor Drugs Product Portfolios and Specifications
Table 80. Roche Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Celgene Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Celgene Targeted Antitumor Drugs Product Portfolios and Specifications
Table 85. Celgene Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Celgene Main Business
Table 87. Celgene Latest Developments
Table 88. Novartis Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Targeted Antitumor Drugs Product Portfolios and Specifications
Table 90. Novartis Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Johnson & Johnson Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Targeted Antitumor Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Lilly Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Lilly Targeted Antitumor Drugs Product Portfolios and Specifications
Table 100. Lilly Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Lilly Main Business
Table 102. Lilly Latest Developments
Table 103. AstraZeneca plc. Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca plc. Targeted Antitumor Drugs Product Portfolios and Specifications
Table 105. AstraZeneca plc. Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AstraZeneca plc. Main Business
Table 107. AstraZeneca plc. Latest Developments
Table 108. Betta Pharmaceuticals Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Betta Pharmaceuticals Targeted Antitumor Drugs Product Portfolios and Specifications
Table 110. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Betta Pharmaceuticals Main Business
Table 112. Betta Pharmaceuticals Latest Developments
Table 1. Targeted Antitumor Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Targeted Antitumor Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Macromolecular Targeted Antitumor Drugs
Table 4. Major Players of Small Molecule Targeted Antitumor Drugs
Table 5. Global Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Targeted Antitumor Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Targeted Antitumor Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Targeted Antitumor Drugs Revenue by Application (2018-2023)
Table 13. Global Targeted Antitumor Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Targeted Antitumor Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Targeted Antitumor Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global Targeted Antitumor Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Targeted Antitumor Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Targeted Antitumor Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Targeted Antitumor Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution and Sales Area
Table 21. Players Targeted Antitumor Drugs Products Offered
Table 22. Targeted Antitumor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Targeted Antitumor Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Targeted Antitumor Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Targeted Antitumor Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Targeted Antitumor Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Targeted Antitumor Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Targeted Antitumor Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Targeted Antitumor Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC Targeted Antitumor Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC Targeted Antitumor Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Targeted Antitumor Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Targeted Antitumor Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Targeted Antitumor Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Targeted Antitumor Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Targeted Antitumor Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Targeted Antitumor Drugs
Table 58. Key Market Challenges & Risks of Targeted Antitumor Drugs
Table 59. Key Industry Trends of Targeted Antitumor Drugs
Table 60. Targeted Antitumor Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Targeted Antitumor Drugs Distributors List
Table 63. Targeted Antitumor Drugs Customer List
Table 64. Global Targeted Antitumor Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Targeted Antitumor Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Targeted Antitumor Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Targeted Antitumor Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Targeted Antitumor Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Targeted Antitumor Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Targeted Antitumor Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Targeted Antitumor Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Targeted Antitumor Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Targeted Antitumor Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Roche Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Targeted Antitumor Drugs Product Portfolios and Specifications
Table 80. Roche Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Celgene Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Celgene Targeted Antitumor Drugs Product Portfolios and Specifications
Table 85. Celgene Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Celgene Main Business
Table 87. Celgene Latest Developments
Table 88. Novartis Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Targeted Antitumor Drugs Product Portfolios and Specifications
Table 90. Novartis Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Johnson & Johnson Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Targeted Antitumor Drugs Product Portfolios and Specifications
Table 95. Johnson & Johnson Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Lilly Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Lilly Targeted Antitumor Drugs Product Portfolios and Specifications
Table 100. Lilly Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Lilly Main Business
Table 102. Lilly Latest Developments
Table 103. AstraZeneca plc. Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca plc. Targeted Antitumor Drugs Product Portfolios and Specifications
Table 105. AstraZeneca plc. Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AstraZeneca plc. Main Business
Table 107. AstraZeneca plc. Latest Developments
Table 108. Betta Pharmaceuticals Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Betta Pharmaceuticals Targeted Antitumor Drugs Product Portfolios and Specifications
Table 110. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Betta Pharmaceuticals Main Business
Table 112. Betta Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Targeted Antitumor Drugs
Figure 2. Targeted Antitumor Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Antitumor Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Targeted Antitumor Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Targeted Antitumor Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Macromolecular Targeted Antitumor Drugs
Figure 10. Product Picture of Small Molecule Targeted Antitumor Drugs
Figure 11. Global Targeted Antitumor Drugs Sales Market Share by Type in 2022
Figure 12. Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Targeted Antitumor Drugs Consumed in Lung Cancer
Figure 14. Global Targeted Antitumor Drugs Market: Lung Cancer (2018-2023) & (K Units)
Figure 15. Targeted Antitumor Drugs Consumed in Lymphoma
Figure 16. Global Targeted Antitumor Drugs Market: Lymphoma (2018-2023) & (K Units)
Figure 17. Targeted Antitumor Drugs Consumed in Breast Cancer
Figure 18. Global Targeted Antitumor Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 19. Targeted Antitumor Drugs Consumed in Leukaemia
Figure 20. Global Targeted Antitumor Drugs Market: Leukaemia (2018-2023) & (K Units)
Figure 21. Targeted Antitumor Drugs Consumed in Prostate Cancer
Figure 22. Global Targeted Antitumor Drugs Market: Prostate Cancer (2018-2023) & (K Units)
Figure 23. Targeted Antitumor Drugs Consumed in Multiple Bone Marrow Cancer
Figure 24. Global Targeted Antitumor Drugs Market: Multiple Bone Marrow Cancer (2018-2023) & (K Units)
Figure 25. Targeted Antitumor Drugs Consumed in Others
Figure 26. Global Targeted Antitumor Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Targeted Antitumor Drugs Sales Market Share by Application (2022)
Figure 28. Global Targeted Antitumor Drugs Revenue Market Share by Application in 2022
Figure 29. Targeted Antitumor Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Targeted Antitumor Drugs Sales Market Share by Company in 2022
Figure 31. Targeted Antitumor Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Targeted Antitumor Drugs Revenue Market Share by Company in 2022
Figure 33. Global Targeted Antitumor Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 44. Americas Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Targeted Antitumor Drugs Sales Market Share by Region in 2022
Figure 52. APAC Targeted Antitumor Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 63. Europe Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2022
Figure 81. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 82. Industry Chain Structure of Targeted Antitumor Drugs
Figure 83. Channels of Distribution
Figure 84. Global Targeted Antitumor Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Targeted Antitumor Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Targeted Antitumor Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Targeted Antitumor Drugs
Figure 2. Targeted Antitumor Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Antitumor Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Targeted Antitumor Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Targeted Antitumor Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Macromolecular Targeted Antitumor Drugs
Figure 10. Product Picture of Small Molecule Targeted Antitumor Drugs
Figure 11. Global Targeted Antitumor Drugs Sales Market Share by Type in 2022
Figure 12. Global Targeted Antitumor Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Targeted Antitumor Drugs Consumed in Lung Cancer
Figure 14. Global Targeted Antitumor Drugs Market: Lung Cancer (2018-2023) & (K Units)
Figure 15. Targeted Antitumor Drugs Consumed in Lymphoma
Figure 16. Global Targeted Antitumor Drugs Market: Lymphoma (2018-2023) & (K Units)
Figure 17. Targeted Antitumor Drugs Consumed in Breast Cancer
Figure 18. Global Targeted Antitumor Drugs Market: Breast Cancer (2018-2023) & (K Units)
Figure 19. Targeted Antitumor Drugs Consumed in Leukaemia
Figure 20. Global Targeted Antitumor Drugs Market: Leukaemia (2018-2023) & (K Units)
Figure 21. Targeted Antitumor Drugs Consumed in Prostate Cancer
Figure 22. Global Targeted Antitumor Drugs Market: Prostate Cancer (2018-2023) & (K Units)
Figure 23. Targeted Antitumor Drugs Consumed in Multiple Bone Marrow Cancer
Figure 24. Global Targeted Antitumor Drugs Market: Multiple Bone Marrow Cancer (2018-2023) & (K Units)
Figure 25. Targeted Antitumor Drugs Consumed in Others
Figure 26. Global Targeted Antitumor Drugs Market: Others (2018-2023) & (K Units)
Figure 27. Global Targeted Antitumor Drugs Sales Market Share by Application (2022)
Figure 28. Global Targeted Antitumor Drugs Revenue Market Share by Application in 2022
Figure 29. Targeted Antitumor Drugs Sales Market by Company in 2022 (K Units)
Figure 30. Global Targeted Antitumor Drugs Sales Market Share by Company in 2022
Figure 31. Targeted Antitumor Drugs Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Targeted Antitumor Drugs Revenue Market Share by Company in 2022
Figure 33. Global Targeted Antitumor Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 36. Americas Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 37. APAC Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 38. APAC Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Europe Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 40. Europe Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Targeted Antitumor Drugs Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Targeted Antitumor Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Americas Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 44. Americas Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 45. Americas Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 46. Americas Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 47. United States Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Targeted Antitumor Drugs Sales Market Share by Region in 2022
Figure 52. APAC Targeted Antitumor Drugs Revenue Market Share by Regions in 2022
Figure 53. APAC Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 54. APAC Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 55. China Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 63. Europe Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 64. Europe Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 65. Europe Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 66. Germany Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Application (2018-2023)
Figure 75. Egypt Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Targeted Antitumor Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2022
Figure 81. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 82. Industry Chain Structure of Targeted Antitumor Drugs
Figure 83. Channels of Distribution
Figure 84. Global Targeted Antitumor Drugs Sales Market Forecast by Region (2024-2029)
Figure 85. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Targeted Antitumor Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Targeted Antitumor Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Application (2024-2029)
